Greenwood Capital Associates’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-24,478
Closed -$459K 235
2020
Q4
$459K Buy
+24,478
New +$399K 0.08% 169
2015
Q4
Sell
-52,841
Closed -$2.13M 174
2015
Q3
$2.13M Buy
52,841
+48,051
+1,003% +$2.68M 0.75% 59
2015
Q2
$325K Sell
4,790
-31
-0.6% -$2.19K 0.1% 106
2015
Q1
$286K Buy
4,821
+590
+14% +$33.6K 0.08% 121
2014
Q4
$239K Buy
+4,231
New +$227K 0.07% 130
2014
Q3
Sell
-99,952
Closed -$5.15M 155
2014
Q2
$5.15M Buy
99,952
+29,106
+41% +$1.43M 1.6% 14
2014
Q1
$3.46M Buy
+70,846
New +$3.44M 1.11% 38

Other funds holding VTRS

Greenwood Capital Associates's VTRS Position: Q1 2021 in Review

Greenwood Capital Associates sold out of Viatris (VTRS) in Q1 2021, closing a stake of 24,478 shares — an estimated $459K sold.

Greenwood Capital Associates first reported a position in VTRS in Q1 2014 and held it in 7 quarters. The position peaked at $5.15M in Q2 2014. 1,116 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Greenwood Capital Associates reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • Greenwood Capital Associates sold 24,478 Viatris shares in Q1 2021, an estimated $459K.
  • Greenwood Capital Associates first reported a position in Viatris in Q1 2014 and held it in 7 quarters.
  • Greenwood Capital Associates's Viatris position peaked at $5.15M in Q2 2014.
  • 1,116 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Greenwood Capital Associates's 13F filing for Q1 2021, filed 14 May 2021.